Differentiation syndrome in patients with acute promyelocytic leukemia

A 48‐year‐old male diagnosed with acute promyelocytic leukemia (APL) started on all‐trans‐retinoic acid and arsenic trioxide, developed typical symptoms of differentiation syndrome, and improved dramatically on steroids. Hence, any APL patient started on chemotherapy, needs to be monitored closely f...

Descripción completa

Detalles Bibliográficos
Autores principales: Elamin, Nusiba H., Rashid, Farah, Afana, Muhammad S., Cherif, Honar, Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880381/
https://www.ncbi.nlm.nih.gov/pubmed/36721680
http://dx.doi.org/10.1002/ccr3.6697
Descripción
Sumario:A 48‐year‐old male diagnosed with acute promyelocytic leukemia (APL) started on all‐trans‐retinoic acid and arsenic trioxide, developed typical symptoms of differentiation syndrome, and improved dramatically on steroids. Hence, any APL patient started on chemotherapy, needs to be monitored closely for developing differentiation syndrome and to start steroid upon suspicion.

Ejemplares similares